Indofarma Tbk. vs Chandra Asri Pacific Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Chandra Asri Pacific Tbk. trades at Rp1,880 (market cap 166.97T, 197.42M 24h volume). The key difference: Chandra Asri Pacific Tbk. is far larger — about 427.6× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.
| INAF | TPIA | |
|---|---|---|
Market Cap | 390.51B | 166.97T |
Volume | — | 197.42M |
Lot | — | 1.97M |
Turnover | — | 373.29B |
Average Price | — | 1,890.87 |
Value | — | 373.29B |
Indicative Equilibrium Price | — | 1,880 |
Indicative Equilibrium Volume | — | 33.45K |
Trailing returns across standard periods
Latest headlines on both assets
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →PT Chandra Asri Petrochemical Tbk formerly PT. Tri Polyta Indonesia, Tbk (the Company) was established under the Domestic Capital Investment Law No. 6 year 1968 and Law No. 12 year 1970 by Notarial Deed No. 40 dated November 2, 1984 of Ridwan Suselo, S.H., notary public in Jakarta. The Company is the largest Indonesia producer of polypropyleneresins that are used in the manufacture of a wide range of consumer products.
Read more on TPIA →